Followers | 439 |
Posts | 41282 |
Boards Moderated | 0 |
Alias Born | 10/07/2010 |
Tuesday, September 15, 2020 9:00:19 AM
https://www.otcmarkets.com/filing/html?id=14389599&guid=iPo6U6A-YO4Lhth
PART III — NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report or portion thereof, could not be filed within the prescribed time period.
The Company is unable to file its Form 10-Q within the prescribed period without unreasonable expense. The Company fully expects to be able to file within the additional time allowed by this report.
PART IV — OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
Mailander Law Office, Tad Mailander (619) 239-9034
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes [X] NO [_]
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes [_] NO [X]
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
GRN Holding Corporation
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 14, 2020 By: /s/ Justin Costello
Chief Executive Officer
Recent GRNF News
- GRN HOLDING CORP ANNOUNCES JOINT VENTURE WITH ONE WORLD LEGENDS ON GLOBAL DISTRIBUTION OF CANNABIS • InvestorsHub NewsWire • 08/15/2023 01:00:00 PM
- GRN Holding Corporation Successfully Completes Merger with Marijuana Inc., Creating a Leading Force in the Cannabis Industry • InvestorsHub NewsWire • 05/23/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM